🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Wearable Devices Faciliate the Management of AMI Patients

Recruitingn/aAges 18 Years - 75 YearsAllRenJi Hospital
NCT06995495 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study will explore the use of wearable technology to consistently monitor patients with acute myocardial infarction (AMI) receiving primary percutaneous coronary intervention (PCI). Parameters such as heart rate, sleep time, physical activity, and blood pressure will be collected and analyzed to characterize the patients and predict clinical outcomes.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Aged 18-75 years old * Diagnosed with STEMI or NSTEMI (ACC/AHA guidelines) * Half male and half female * Undergo CAG and PCI treatment; * Written informed consent. Exclusion Criteria: * People under the age of 18 years old; * Patients who are pregnant/breastfeeding; * Patients who are allergic to the metallic or plastic components of the wearable devices
💊

What it tests

  • Not listed
📍

Where

1 site
Renji Hospital
Shanghai, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy